Global Biomarker Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Biomarker Market Insights, Forecast to 2034
Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic intervention."
Market Analysis and InsightsGlobal Biomarker Market
Global Biomarker market is expected to reach to US$ 33190 million in 2023, with a positive growth of %, compared with US$ 28570 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biomarker industry is evaluated to reach US$ 68010 million in 2033. The CAGR will be 12.7% during 2023 to 2033.
Globally, Biomarker key companies include F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG, General Electric, Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and QIAGEN, etc. F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Biomarker were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biomarker market and estimated to attract more attentions from industry insiders and investors.
Biomarker can be divided into Consumables and Service, etc. Consumables is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Biomarker is widely used in various fields, such as Diagnostics Development, Drug Discovery and Development, Disease-Risk and Other, etc. Diagnostics Development provides greatest supports to the Biomarker industry development. In 2022, global % revenue of Biomarker went into Diagnostics Development filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biomarker market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biomarker market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN
Segment by Type
Consumables
Service
Diagnostics Development
Drug Discovery and Development
Disease-Risk
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biomarker introduction, etc. Biomarker Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Biomarker
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Biomarker Market
Global Biomarker market is expected to reach to US$ 33190 million in 2023, with a positive growth of %, compared with US$ 28570 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biomarker industry is evaluated to reach US$ 68010 million in 2033. The CAGR will be 12.7% during 2023 to 2033.
Globally, Biomarker key companies include F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG, General Electric, Johnson & Johnson Services, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH and QIAGEN, etc. F. Hoffmann-La Roche Ltd., Abbott, Epigenomics AG are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Biomarker were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Biomarker market and estimated to attract more attentions from industry insiders and investors.
Biomarker can be divided into Consumables and Service, etc. Consumables is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Biomarker is widely used in various fields, such as Diagnostics Development, Drug Discovery and Development, Disease-Risk and Other, etc. Diagnostics Development provides greatest supports to the Biomarker industry development. In 2022, global % revenue of Biomarker went into Diagnostics Development filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Biomarker market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Biomarker market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
F. Hoffmann-La Roche Ltd.
Abbott
Epigenomics AG
General Electric
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Siemens Healthcare GmbH
QIAGEN
Segment by Type
Consumables
Service
Segment by Application
Diagnostics Development
Drug Discovery and Development
Disease-Risk
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Biomarker introduction, etc. Biomarker Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Biomarker
Chapter 13Methodology and Data Sources adopted by MRAResearch